Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02013804
Title A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

melanoma

renal cell carcinoma

Therapies

MEDI0680

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site New Haven Connecticut 06511 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site The Bronx New York 10461 United States Details
Research Site Portland Oregon 97213 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field